Immune Disorders Drugs Market Research Reports

HAE Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Ongoing Shift towards Plasma-Derivative Products and Expected Launch of Premium Therapies - Product Thumbnail Image

HAE Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Ongoing Shift towards Plasma-Derivative Products and Expected Launch of Premium Therapies

  • Report
  • 92 Pages
From
Global Immunology Drugs Market to 2023 - Shifting Landscape as Uptake of Interleukin Receptor Inhibitors Offsets Losses for Top Blockbuster Drugs - Product Thumbnail Image

Global Immunology Drugs Market to 2023 - Shifting Landscape as Uptake of Interleukin Receptor Inhibitors Offsets Losses for Top Blockbuster Drugs

  • Report
  • 181 Pages
From
Uveitis Therapeutics in Asia-Pacific Markets to 2023 - Increasing Prevalence, Continued Uptake of Biologics and Novel Pipeline Drugs to Drive the Market - Product Thumbnail Image

Uveitis Therapeutics in Asia-Pacific Markets to 2023 - Increasing Prevalence, Continued Uptake of Biologics and Novel Pipeline Drugs to Drive the Market

  • Report
  • 91 Pages
From
Research Antibodies and Reagents Market - Global Opportunity Analysis and Industry Forecast (2018-2023) - Product Thumbnail Image

Research Antibodies and Reagents Market - Global Opportunity Analysis and Industry Forecast (2018-2023)

  • Report
  • 321 Pages
From
Neuroscience Antibodies & Assays Market by Product (Reagent (Media, Sera, Stain, Enzymes, Probe), Instruments), Technology (Immunoassay, Molecular Diagnostics), Application (IVD) & End User (Research Institute, Hospital) - Global Forecast to 2023 - Product Thumbnail Image

Neuroscience Antibodies & Assays Market by Product (Reagent (Media, Sera, Stain, Enzymes, Probe), Instruments), Technology (Immunoassay, Molecular Diagnostics), Application (IVD) & End User (Research Institute, Hospital) - Global Forecast to 2023

  • Report
  • 158 Pages
From
Epiomic Epidemiology Series: Mucopolysaccharidosis Type I Forecast In 27 Major Markets 2018–2028 - Product Thumbnail Image

Epiomic Epidemiology Series: Mucopolysaccharidosis Type I Forecast In 27 Major Markets 2018–2028

  • Report
  • 74 Pages
From
Epiomic Epidemiology Series: Mucopolysaccharidosis Type IV Forecast In 28 Major Markets 2018–2028 - Product Thumbnail Image

Epiomic Epidemiology Series: Mucopolysaccharidosis Type IV Forecast In 28 Major Markets 2018–2028

  • Report
  • 88 Pages
From
Autoimmune Disease Diagnosis Market by Products (Consumables, Assay Kits, Instruments, Services), Test Type (Inflammatory Markers, Autoantibodies), Disease (Thyroiditis, Scleroderma), End Users (Hospitals, Clinical Labs) - Global Forecast to 2022 - Product Thumbnail Image

Autoimmune Disease Diagnosis Market by Products (Consumables, Assay Kits, Instruments, Services), Test Type (Inflammatory Markers, Autoantibodies), Disease (Thyroiditis, Scleroderma), End Users (Hospitals, Clinical Labs) - Global Forecast to 2022

  • Report
  • 123 Pages
From
Global Dermatology Drugs Market to 2023 - Growth Driven by Increased Uptake of Interleukin Receptor Inhibitors for Psoriasis and Atopic Dermatitis - Product Thumbnail Image

Global Dermatology Drugs Market to 2023 - Growth Driven by Increased Uptake of Interleukin Receptor Inhibitors for Psoriasis and Atopic Dermatitis

  • Report
  • 136 Pages
From
Allergic Rhinitis Forecast in 26 Major Markets 2018-2028 - Product Thumbnail Image

Allergic Rhinitis Forecast in 26 Major Markets 2018-2028

  • Report
  • 88 Pages
From
Rhinitis: Market Intelligence Review and Insights - Product Thumbnail Image

Rhinitis: Market Intelligence Review and Insights

  • Report
  • 50 Pages
From
Transplantation Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Transplantation Drug Development Pipeline Review, 2017

  • Report
  • 242 Pages
From
Research Antibodies Market by Product (Antibodies (Primary, Secondary)(Mouse, Rabbit)), Reagents), Technology (Western Blot, Flow Cytometry, Elisa, Immunofluorescence, Immunohistochemistry), Application, & End User - Global Forecast to 2022 - Product Thumbnail Image

Research Antibodies Market by Product (Antibodies (Primary, Secondary)(Mouse, Rabbit)), Reagents), Technology (Western Blot, Flow Cytometry, Elisa, Immunofluorescence, Immunohistochemistry), Application, & End User - Global Forecast to 2022

  • Report
  • 281 Pages
From
Rhinitis: Epidemiology Overview and Insights - Product Thumbnail Image

Rhinitis: Epidemiology Overview and Insights

  • Report
  • 50 Pages
From
Immunochemicals - Global Strategic Business Report - Product Thumbnail Image

Immunochemicals - Global Strategic Business Report

  • Report
  • 281 Pages
From
Intravenous Immunoglobulin (IVIg) - Global Strategic Business Report - Product Thumbnail Image

Intravenous Immunoglobulin (IVIg) - Global Strategic Business Report

  • Report
  • 187 Pages
From
Monoclonal Antibodies - Global Trends in the Competitive, Technological and R&D Landscape - Product Thumbnail Image

Monoclonal Antibodies - Global Trends in the Competitive, Technological and R&D Landscape

  • Report
  • 57 Pages
From
Frontier Pharma: Women's Health - An Expanding Therapy Area, with Endometriosis Therapies Prominent among the First-in-Class Pipeline - Product Thumbnail Image

Frontier Pharma: Women's Health - An Expanding Therapy Area, with Endometriosis Therapies Prominent among the First-in-Class Pipeline

  • Report
  • 86 Pages
From
Frontier Pharma: Transplantation Therapeutics - A Highly Innovative Pipeline with a Range of Adaptive and Innate Immune-Targeting Programs Focusing on Graft-Versus-Host Disease and Kidney Transplantation - Product Thumbnail Image

Frontier Pharma: Transplantation Therapeutics - A Highly Innovative Pipeline with a Range of Adaptive and Innate Immune-Targeting Programs Focusing on Graft-Versus-Host Disease and Kidney Transplantation

  • Report
  • 72 Pages
From
Frontier Pharma: Cancer Immunotherapies - First-in-Class Pipeline Dominated by Immunomodulators and PD-1 Like Targets - Product Thumbnail Image

Frontier Pharma: Cancer Immunotherapies - First-in-Class Pipeline Dominated by Immunomodulators and PD-1 Like Targets

  • Report
  • 135 Pages
From
Loading Indicator
adroll